Scientist , Analytical Development - Protein Chemistry; Temporary
Listed on 2026-09-21
-
Research/Development
Research Scientist, Data Scientist
Scientist I, Analytical Development - Protein Chemistry (Temporary)
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
THE OPPORTUNITYVir Biotechnology seeks aTemporary Staff analytical chemist tosupportthe characterization of therapeutic molecules across a broad modality of products at various clinical stages. The successful candidate willbe responsible for supporting the operation of analytical development labs, including a mass spectrometry facility, and be a key memberonproject teams. Additionally, this individual willbe responsible forhands-on analytical support for process development, method development, and product characterization studies of proteins and oligonucleotides, such as forced degradation,comparability and structure-activity relationship studies.
This roleis located inour San Francisco headquarters with an expectation of at least 4 days per week in office.
WHAT YOU'LL DO- Hands-on analytical lab support for process development, formulation development, analytical methods development, and product characterization for projects at various clinical stages
- Perform all relevant analytical testing and report results in collaboration with the process development and drug product teams
- Apply mass spectrometry techniques and other analytical methods to support characterization of Vir products
- Stay current with emerging trends in protein or oligonucleotide analytics and introduce new technology to enhance workflow and capabilities
- Work cross-functionally within CMC with process and formulation development, QC and QA to meet program deliverables
- Perform forced degradation, comparability, structure-activity relationship studies to evaluate Vir products (e.g., for aggregation, charge variants, post-translational modifications, etc.), and perform CQA assessments
- Manage method development and characterization testing at external partners by providing technical review of protocols, reports, data analysis, and troubleshooting method-related issues
- Draft and review relevant sections of global regulatory filings
- Author study protocols, development/qualification reports, test methods, relevant sections of regulatory submissions, and responses to agency questions
- Ph.D. in Analytical Chemistry, Biochemistry, or related fields with0+years (or MS with4+ years, or BS with6+ years) of relevant experience in analytical development and characterization of protein therapeutics in the biotechnology industry
- Technicalexpertiseand hands-on experience in characterization of biologics and associated impurities with U/HPLC, CE-SDS, andiCIEFassays.
Ability to collect, process,interpret, and presentanalyticaldata independently. - Knowledge and hands-on experience instate-of-the-art protein mass spectrometry techniques (instrumentation and data analysis software).Previous experience on oligonucleotide mass spectrometry analysis is a plus
- Ability to investigate…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).